Gene Query: CD55

Dataset Description Geneva Score
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 500.99
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 229.98
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 118.48
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 105.28
The role of the Calcium-Sensing receptor in colorectal cancer 100.04
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 91.16
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 81.77
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 80.65
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 75.5
Differential expression of genes in AD169-infected MRC5. 74.34
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 72.08
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 71.92
WRN knockout effects upon gene expression in SW48 and OVK18 71.69
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 69.9
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 64.49
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 63.71
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 62.84
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 58.0
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 57.34
Statins modulate endothelial transcriptional profile by inhibiting EZH2 56.67
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 56.35
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 55.49
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 55.14
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 54.81
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 52.47
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 49.49
Effect of BB608 on Gene Expression in HNSCC Cell Line 48.02
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 47.57
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 44.49
Changes in human endometrial gland transcriptome over the window of implantation 43.97
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 43.46
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 42.28
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 42.28
TCF7L1 knockdown in pancreatic cancer 42.09
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 41.86
Molecular Mechanisms of Endothelial Hyperpermeability 41.47
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 41.19
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 41.09
Effect of Influenza virus infection on lncRNA expression in A549 cells 40.86
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 40.71
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 40.71
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 40.44
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 40.42
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 39.59
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 39.54
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 39.54
RNA-sequencing of human tendon after injury 39.31
AR-independent prostate cancer is sustained through FGF signaling 39.17
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 38.75
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 38.75
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 38.62
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 38.26
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 38.01
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 37.52
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 37.06
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 36.91
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 36.69
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 36.58
RNA-seq analyses of human prostate cancer cells 36.45
BAF controls genome accessibility 36.39
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 36.37
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 36.35
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 33.75
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 33.64
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 33.64
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 32.48
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 31.67
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 31.57
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 30.98
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 30.98
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 30.93
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 30.38
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 30.3
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 29.93
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 29.5
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 29.5
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 29.4
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 28.86
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 28.82
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 28.5
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 28.27
Endometrial transcriptome and PGR cistrome in cycling fertile women 28.27
The DPYSL2 gene connects mTOR and schizophrenia 27.61
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 27.42
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 27.42
Landscape of H3K4me3 in human CD19 cells 27.3
RNA Sequencing of three pairs of gastric cancer 27.27
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 27.15
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 26.98
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 26.53
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 26.36
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 26.32
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 26.32
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 26.3
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 26.3
RNA expression following TMPRSS11B overexpression or depletion 26.28
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 25.91
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 25.78
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 25.65
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 25.55
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 25.55
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 25.49
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 25.33
Transcriptomic and gene ontology profiling of the human corneal cell types 25.18
Role of microRNAs in the interaction between Salmonella and the host cell 25.0
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 24.92
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 24.75
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 24.74
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 24.54
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 23.97
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 23.96
MCF10A H-Ras RNA-Seq 23.85
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 23.81
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 23.67
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 23.34
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 23.29
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 23.05
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 23.02
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 23.02
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 23.02
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 23.01
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 22.98
Fbxo32 mediated gene expression program underlies EMT and metastasis 22.86
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 22.82
Genome-wide analysis of Dengue virus 2 infected cells 22.81
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 22.66
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 22.61
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 22.59
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 22.57
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 22.42
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 22.42
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 22.31
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 22.06
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 22.01
Single-nucleotide-resolution mapping of HBV promoters using CAGE 21.87
Biological effect of chronic mistranslation in mammalian cells 21.63
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 21.52
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 21.5
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 21.42
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 21.23
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 21.18
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 20.94
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 20.89
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 20.85
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 20.78
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 20.7
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 20.56
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 20.32
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 20.24
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 19.93
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 19.77
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 19.75
Fibroblasts in cholesteatoma activate osteoclasts. 19.69
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 19.66
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 19.66
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 19.64
Loss of endometrial plasticity in recurrent pregnancy loss 19.64
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 19.57
Transcriptomic profiling of human peripheral blood-derived mast cells 19.57
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 19.44
Nonpregnant and term pregnant human myometrial tissues 19.44
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 19.41
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 19.34
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 19.33
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 19.27
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 19.24
RNA-seq of stable and unstable section of human atherosclerotic plaques 19.0
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 18.93
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 18.85
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 18.79
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 18.73
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 18.61
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 18.6
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 18.6
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 18.59
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 18.59
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 18.46
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 18.44
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 18.43
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 18.35
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 18.35
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 18.27
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 18.23
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 18.08
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 18.02
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 18.02
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 17.98
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 17.98
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 17.96
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 17.94
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 17.92
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 17.85
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 17.72
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 17.68
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 17.68
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 17.58
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 17.52
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 17.52
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 17.52
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 17.52
Maturation of human iNSCs 17.5
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 17.5
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 17.48
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 17.46
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 17.39
Effect of disulfiram treatment on pediatric high grade glioma 17.36
MYCi975 regulates MYC target genes 17.29
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 17.28
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 17.28
ARID1A regulates condensin II distribution and chromosomal partition 17.28
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 17.21
Inhibition of TNBC metastasis by Gpx1 17.17
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 17.03
Human neutrophil genome during PMA- and E. coli encounter-induced activation 17.03
Functional role of SLIT2 and ROBO1 in trophoblasts 17.02
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 17.02
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 16.86
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 16.85
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 16.83
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 16.83
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 16.8
Neurofibroma 16.8
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 16.75
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 16.71
Transcriptome wide analysis of classically and alternatively activated macrophages 16.69
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 16.62
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 16.54
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 16.53
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 16.47
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 16.47
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 16.31
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 16.31
p63 controls the enhancer landscape during keratinocyte differentiation 16.29
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 16.28
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 16.24
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 16.2
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 16.19
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 16.13
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 16.11
Expression profiling of converted and control dermal BJ fibroblasts 16.1
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 16.1
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 16.01
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 16.01
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 16.0
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 16.0
Co-regulation of splicing by Rbfox1 and hnRNP M 16.0
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 15.99
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 15.95
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 15.86
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 15.73
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 15.63
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 15.61
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 15.61
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 15.55
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 15.53
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 15.51
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 15.47
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 15.45
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 15.44
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 15.4
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 15.39
Effect of from Human Umbilical Vein Endothelial Cells 15.34
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 15.33
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 15.25
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 15.03
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 15.02
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 14.98
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 14.97
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 14.97
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 14.95
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 14.95
RNAseq of IL-36 stimulated primary human keratinocytes 14.7
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 14.66
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 14.6
Human Treg NaCl stimulation 14.57
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 14.54
Cleavage Factor Im as a key regulator of 3’ UTR length 14.41
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 14.4
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 14.38
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 14.38
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 14.35
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 14.3
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 14.26
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 14.2
Ro60-knockout cells 14.19
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 14.12
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 14.09
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 14.09
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 14.02
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 13.95
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 13.85
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 13.81
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 13.74
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 13.7
RNA seq comparison between scrambled and shGRP78 cells 13.69
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 13.53
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 13.42
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 13.4
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 13.37
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 13.33
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 13.32
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 13.29
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.23
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.23
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 13.14
Global transcriptome analysis of HAP1 cells 13.01
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 12.94
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 12.94
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 12.83
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 12.77
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 12.63
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 12.62
The effect of Abl kinases on non-small cell carcinoma global transcriptome 12.54
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 12.39
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 12.36
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 12.25
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 11.95
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 11.95
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 11.76
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 11.71
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 11.68
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 11.58
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 11.44
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 11.44
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 11.37
Transciptomic profiling of human fetal lung samples 11.34
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 11.33
Transcriptional profiling of LS1034 cells treated with tepoxalin 11.17
MicroRNA targetome analysis during HCMV infection 11.16
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 11.04
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 11.04
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 10.83
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 10.83
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 10.8
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 10.78
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 10.78
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 10.47
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 10.46
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 10.43
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 10.37
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 10.37
RNA sequencing of human mammary epithelial cells 10.08
ARID1A and ARID1B loss in HCT116 cells 10.01
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 10.0
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 9.83
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 9.83
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 9.79
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 9.75
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 9.64
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 9.6
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 9.48
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 9.42
Targeting MTHFD2 in Acute Myeloid Leukemia 9.39
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 9.36
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 9.32
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 9.22
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 9.2
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 9.13
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 9.12
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 8.75
Gene Expression Profiling of WT and KDM3A Knocked out Cell 8.68
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 8.68
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 8.67
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 8.67
Argonaute proteins couple chromatin silencing to alternative splicing 8.63
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 8.63
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 8.42
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 8.37
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 8.34
RNA expression analysis upon JMJD1C depletion 8.34
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 8.2
An siRNA screen identifies CHD4 as a target for epigenetic therapy 8.18
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 8.12
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 8.12
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 8.04
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.0
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 7.96
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 7.93
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 7.93
Effect of nuclear IL-33 on gene expression 7.82
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 7.79
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 7.59
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 7.45
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 7.26
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 7.15
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 7.15
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 7.0
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.93
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 6.88
Cell responses to dysregulated VZV-induced cell-cell fusion 6.64
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.6
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 6.6
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 6.6
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 6.57
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.54
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 6.45
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 6.15
Proliferation-correlated expression 6.07
oxLDL exposed trained monocytes 5.98
Transcriptomes of oxLDL exposed trained monocytes 5.98
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.9
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 5.6
Transcriptome sequencing of K-562 cells 5.53
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 5.43
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.4
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 5.4
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 5.32
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 5.29
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 5.24
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 5.22
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 5.19
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.16
Positively selected enhancer elements endow tumor cells with metastatic competence 5.08
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.95
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.95
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.94
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.93
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 4.77
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.74
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.7
Primary Human B-cell Temporal Response to CD40L Stimulation 4.69
RNA sequencing analysis of selumetinib-resistant CRC cells lines 4.63
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 4.42
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 4.41
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.3
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.25
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.25
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 3.94
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 3.89
3.86
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.83
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.77
Random mono-allelic expression in MECP2-mutated cells 3.77
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 3.76
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.6
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.6
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 3.6
Role of cervicovaginal microbiota in genital inflammation 3.59
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.59
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 3.55
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 3.55
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.46
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.42
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 3.21
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 2.99
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.93
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.93
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.86
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 2.79
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.72
Transcriptomes of human monocytes after ex vivo exposure to uric acid 2.68
Gene expression profile in breast cancer cells 2.59
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.59
RNA sequencing of human pancreatic cancer cell lines 2.57
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 2.25
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 2.2
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.2
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.2
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 2.19
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 2.19
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 2.19
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 2.04
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.98
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.9
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.83
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 1.67
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.65
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.49
Transcriptome profiling of 5 human adenocarcinoma cell lines 1.49
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.45
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.43
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.38
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.23
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.13
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.13
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.1
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.1
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.09
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 1.04
Gene expression alterations of pancreatic intraepithlial neoplasia 1.03
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.97
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.95
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.95
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.9
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.84
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.77
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.74
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.7
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.69
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.68
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.53
Common inflammatory pathways between NEC and Crohn's disease 0.44
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.43
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.37
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 0.37
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.31
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.15
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.1
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.08
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation